#$%^&*AU2019204913A120190725.pdf#####I: sxd Interwovn NRPortbl DCC SXD 15256822 _.docx-1807/2017 ABSTRACT Oligonucleotide analogues conjugated to carrier peptides are provided. The disclosed compounds are useful for the treatment of various diseases, for example diseases 5 where inhibition of protein expression or correction of aberrant mRNA splice products produces beneficial therapeutic effects.